Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
S2303, Randomized Phase II/III Trial of Second-Line Nivolumab Plus Paclitaxel and Ramucirumab Versus Paclitaxel and Ramucirumab in Patients With PD-L1 CPS =1 Advanced Gastric or Esophageal Adenocarcinoma (PARAMUNE)
Overview
sponsor award id
PROTOCOL S2303
Biography
contributor
Principal Investigator
Time
start date
2024-06-10
end date
2034-06-09